Re: BIO Investor Forum, Oct 22-23

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BIO Investor Forum, Oct 22-23

in response to

Re: BIO Investor Forum, Oct 22-23

iconoclast

posted on Oct 23, 2019 06:38PM

Hmmm. I don't see any slide deck on the Zenith website. Usually they are pretty prompt at posting at time of presentation. I don't have the energy right now (long day), but if someone is motivated they should contact Zenith IR about the slide deck from today's Bio Investor Forum presentation.